Thomas Woiwode - Insider Trading & Ownership

Entity
Individual
Location
One Sansome Street, Suite 1650, San Francisco, California
Summary
The estimated net worth of Thomas Woiwode is at least $5 M dollars as of May 26, 2023. Thomas Woiwode is the Director of Tempest Therapeutics, Inc. and owns shares of Tempest Therapeutics, Inc. (TPST) stock worth about $5 M. Thomas Woiwode is the Director of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. (GRTS) stock worth about $244.
All Insider Reports
All Insider Reports

Ownership of Thomas Woiwode

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
TPST Tempest Therapeutics, Inc. Director $5 M Jun 17, 2022
GRTS Gritstone bio, Inc. Director $244 Aug 25, 2021
ADVM Adverum Biotechnologies, Inc. Director May 12, 2021
ALGS Aligos Therapeutics, Inc. Director Jun 23, 2022
PASG Passage BIO, Inc. Director, 10%+ Owner May 25, 2023

Insider Transactions Reported by Thomas Woiwode:

Sym Company Class Transaction % Value $ Price $ Shares Shares After Date Ownership